The Australian rare earths producer Lynas Rare Earths is staging an impressive market recovery. After facing pressure in early November, the company’s equity has surged, climbing more than 5% in just a few trading sessions. This upward momentum is fueled by a significant bank upgrade and fresh data highlighting a worsening global shortage of critical minerals. The question for investors is whether this represents a temporary bounce or the beginning of a more sustained upward trend.
Deepening Supply Crunch Underpins Value
Recent industry analysis has cast a spotlight on a rapidly tightening market for heavy rare earth elements, specifically Dysprosium and Terbium. Western nations are confronting what experts describe as a “fundamental geological problem”—there are simply very few viable alternatives to China’s current dominance in this sector. Lynas operates the only significant processing facility for these materials outside of China and is currently undertaking a major expansion. The company aims to ramp up its annual output to 250 tonnes of Dysprosium and 50 tonnes of Terbium, positioning itself as a crucial supplier.
This strategic importance was further cemented by an agreement finalized in October between the Australian government and the Trump Administration. With a funding pipeline of $8.5 billion earmarked for critical mineral projects, Lynas is now solidly in the focus of efforts to secure Western supply chains.
Should investors sell immediately? Or is it worth buying Lynas?
Major Banks Issue Bullish Upgrades
The rally received a substantial boost this week when the investment bank UBS raised its rating on Lynas to “Buy.” In a confident move, the bank also lifted its price target by a considerable 17% to A$17.80. The rationale behind this upgrade is clear: Lynas faces virtually no competition outside of China in the production of heavy rare earths. These elements are essential components for the high-performance magnets used in electric vehicles and advanced military technology.
Market researcher Dim Ariyasinghe at UBS projects that once the company’s current expansion projects are fully operational, they could contribute an additional A$700 million in revenue starting from the 2028 fiscal year. This positive sentiment was prefigured in early November when Macquarie assigned the company an “Outperform” rating, noting that the market for Neodymium and Praseodymium remains structurally tight despite periodic market volatility.
Technical Indicators Signal Strength
From a chart perspective, Lynas shares have convincingly rebounded from their early-November dip, which was triggered by temporary uncertainty around US-China trade negotiations. Closing at A$15.71, the stock is now trading comfortably above its 50-day moving average. Market watchers have identified the A$16.00 level as the next key psychological barrier. Analysts suggest there is potential for a further 13% to 15% appreciation, contingent on the company receiving the necessary regulatory approvals for its new production lines as scheduled.
Ad
Lynas Stock: Buy or Sell?! New Lynas Analysis from November 21 delivers the answer:
The latest Lynas figures speak for themselves: Urgent action needed for Lynas investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 21.
Lynas: Buy or sell? Read more here...
